Factor XIII

CPT: 85291
Print Share

Test Details

Synonyms

  • Factor XIII, Qualitative
  • Fibrin Stabilizing Factor

Use

This is a screening assay and will detect homozygous deficiency of factor XIII.

Limitations

This assay is a screening assay only. It will only be abnormal when factor XIII levels are less than 1% to 2%. To determine FXIII activity, a quantitative functional FXIII assay is recommended.

Methodology

Clot solubility.6 The plasma is treated with thrombin to induce clot formation and the clot is transferred to a 5 molar urea solution. Clots from individuals with normal factor XIII levels are stable for at least 24 hours while clots from factor XIII deficient individuals will dissolve rapidly.

Reference Interval

Normal

Additional Information

Factor XIII is a large (320 kilodalton) tetrameric molecule that is composed of two A-chains and two B-chains, A2B2.6-8 Factor XIII is activated by thrombin in the presence of calcium. The primary function of activated factor XIII (XIIIa) is to catalyze the formation of covalent bonds between fibrin molecules stabilizing the fibrin clot. Factor XIII converts loosely hydrogen-bonded monomers into covalently bonded fibrin polymer. The resultant clot has increased tensile strength and is resistant to fibrinolysis. Factor XIII deficiency should be considered when a patient with excessive bleeding has both normal protime (PT) and activated partial thromboplastin time (aPTT).6

Congenital factor XIII deficiency is rare (less than one case per million individuals) and is inherited as an autosomal recessive trait.6 Individuals who are heterozygous for the deficiency are generally asymptomatic, although some cases of bleeding in heterozygotes have been reported with provocation.9 Homozygotes have symptoms than can present as umbilical stump bleeding, bleeding after circumcision, and excessive bleeding during teething.6 Intracranial hemorrhage can occur spontaneously in up to 30% of cases. The homozygous condition is associated with spontaneous abortions in females and infertility in males.6 Excessive bleeding can be observed after trauma or surgical procedures and wound healing can be delayed. Acquired deficiency can occur due to autoantibody production to factor XIII. Autoantibody development can sometimes occur in association with certain drugs, including isoniazid, penicillin, and phenytoin.6 Factor XIII levels can also become decreased in individuals with disseminated intravascular coagulation, severe liver disease, acute leukemia, Henoch-Schönlein purpura, Crohn's disease, or ulcerative colitis.7

Specimen Requirements

Specimen

Plasma, frozen

Volume

2 mL

Minimum Volume

1 mL

Container

Blue-top (sodium citrate) tube

Patient Preparation

Avoid warfarin (Coumadin®) therapy for two weeks and heparin therapy for two days prior to the test. Do not draw from an arm with a heparin lock or heparinized catheter.

Collection

Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples unless the sample is collected using a winged (butterfly) collection system. With a winged blood collection set a discard tube should be drawn first to account for the dead space of the tubing and prevent under-filling of the evacuated tube.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternative anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.

Storage Instructions

Freeze.

Causes for Rejection

Gross hemolysis; clotted specimen; frozen specimen thawed in transit; improper labeling

Clinical Information

Special Instructions

If the patient's hematocrit exceeds 55%, the volume of citrate in the collection tube must be adjusted. Refer to Coagulation Collection Procedures for directions.

Footnotes

1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997 Jan; 107(1):105-110. 8980376
2. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998 Jun; 109(6):754-757. 9620035
3. National Committee for Clinical Laboratory Standardization. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays. Approved Guideline. 5th ed. Villanova, Pa: NCCLS; 2008. Document H21-A5:28(5).
4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol. 1997 Jun; 107(6):681-683. 9169665
5. McGlasson DL, More L, Best HA, Norris WL, Doe RH, Ray H. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999 May-Jun; 12(3):137-139. 10539100
6. Roberts HR, Escobar MA.. Less common congenital disorders of hemostasis. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. Philadelphia, Pa: WB Saunders Co; 2002: 57-71.
7. Adcock DM, Bethel MA, Macy PA. Coagulation Handbook. Aurora, Colo: Esoterix−Colorado Coagulation; 2006.
8. Triplett DA. Coagulation abnormalities. In: McClatchey KD, ed. Clinical Laboratory Medicine. 2nd ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2002:1033-1049.
9. Schroeder V, Kohler HP. Is heterozygous factor XIII deficiency associated with pregnancy loss? A case report. J Thromb Haemost. 2007; 5(S2):P-w-031.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
086330 Factor XIII 3241-7 086330 Factor XIII 3241-7
Reflex Table for Factor XIII
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 086331 Please Note: 086331 Please Note: N/A

For Providers

Please login to order a test.

 

© 2017  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf